A detailed history of Accredited Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Accredited Wealth Management, LLC holds 71 shares of BMY stock, worth $3,323. This represents 0.28% of its overall portfolio holdings.

Number of Shares
71
Previous 8,237 99.14%
Holding current value
$3,323
Previous $381 Million 2.57%
% of portfolio
0.28%
Previous 0.31%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$43.31 - $48.98 $353,669 - $399,970
-8,166 Reduced 99.14%
71 $371 Million
Q1 2025

May 14, 2025

SELL
$53.9 - $63.11 $11,426 - $13,379
-212 Reduced 2.51%
8,237 $502 Million
Q4 2024

Feb 14, 2025

BUY
$51.92 - $59.94 $438,672 - $506,433
8,449 New
8,449 $478 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Accredited Wealth Management, LLC Portfolio

Follow Accredited Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accredited Wealth Management, LLC with notifications on news.